October 1, 2015
Teva’s Phase 2B Migraine Program
Teva Pharmaceutical Industries Ltd., has announced that Lancet Neurology published online, as back-to-back articles, the results from two Phase 2b…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Teva
September 29, 2015
Teva’s COPAXONE approved in Japan for the Prevention of Relapse of Multiple Sclerosis
Teva Pharmaceutical Industries Ltd. announced on Monday that its glatiramer acetate injection was approved by the Japanese Ministry of Health, Labour and Welfare (MHLW)…